MedPath

An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors

Completed
Conditions
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Radiomics
Interventions
Other: Radiomics model to classify between IPF with UIP pattern and ILDs without UIP pattern
Registration Number
NCT05784207
Lead Sponsor
Maastricht University
Brief Summary

The purpose of this study is to compare AI performance to doctor's performance in the evaluation of IPF/UIP and ILDs without UIP(proven by biopsy).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
145
Inclusion Criteria
  • the availability of non-contrast-enhanced HRCT
Exclusion Criteria
  • the use of contrast enhancement
  • images containing metal or motion artifacts
  • Images reconstructed with a slice thickness larger than 1.5 mm

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NormalRadiomics model to classify between IPF with UIP pattern and ILDs without UIP patternNormal healthy patients
IPF/UIP_Biopsy basedRadiomics model to classify between IPF with UIP pattern and ILDs without UIP patternpatients with a final diagnosis of IPF but a less typical HRCT pattern( lung biopsy required for the diagnosis)
ILD but not IPF and prove by biopsy not UIPRadiomics model to classify between IPF with UIP pattern and ILDs without UIP patternpatients with an ILD and a pathological non-UIP pattern
IPF/UIP_CT basedRadiomics model to classify between IPF with UIP pattern and ILDs without UIP patternpatients with an ILD and a pathological UIP pattern and a final diagnosis of IPF
Primary Outcome Measures
NameTimeMethod
The performance of Radiomics algorithm compared to the ground truthMay 2021

Reporting the performance measure: accuracy

Secondary Outcome Measures
NameTimeMethod
Comparing the performance of the radiomics algorithm to that of physiciansJune 2021

Correctness of the diagnosis - the most probable thin-section pattern (dichotomous outcome: yes or no)

Trial Locations

Locations (1)

Maastricht University

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath